The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127161322 12716132 2 F 20160829 20160906 20160906 EXP US-CIPLA LTD.-2016US17881 CIPLA NOAH S. PHILIP. AN ARIPIPRAZOLE DISCONTINUATION SYNDROME. RHODE ISLAND MEDICAL JOURNAL. 2013;96 (2):13 TO 14 0.00 Y 0.00000 20160906 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127161322 12716132 1 PS CITALOPRAM CITALOPRAM HYDROBROMIDE 1 Unknown 80 MG, PER DAY, UNK Y U 77044 80 MG
127161322 12716132 2 SS CITALOPRAM CITALOPRAM HYDROBROMIDE 1 Unknown 40 MG, UNK Y U 77044 40 MG
127161322 12716132 3 SS CITALOPRAM CITALOPRAM HYDROBROMIDE 1 Unknown 60 MG, UNK Y U 77044 60 MG
127161322 12716132 4 SS TOPIRAMATE. TOPIRAMATE 1 Unknown 100 MG, TWICE DAILY U U 0 100 MG BID
127161322 12716132 5 SS ARIPIPRAZOLE. ARIPIPRAZOLE 1 Unknown 15 MG, PER DAY Y U 0 15 MG
127161322 12716132 6 SS ARIPIPRAZOLE. ARIPIPRAZOLE 1 Unknown 5 MG, UNK Y U 0 5 MG
127161322 12716132 7 SS CLONAZEPAM. CLONAZEPAM 1 Unknown 1 MG, THREE TIMES A DAY U U 0 1 MG
127161322 12716132 8 SS TRAZODONE TRAZODONE HYDROCHLORIDE 1 Unknown 50 MG, AT BEDTIME U U 0 50 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127161322 12716132 4 Migraine

Outcome of event

Event ID CASEID OUTC COD
127161322 12716132 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127161322 12716132 Akathisia
127161322 12716132 Anxiety
127161322 12716132 Drug ineffective
127161322 12716132 Drug withdrawal syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found